RegulyzeMangiferine
Mangifera indica · Leaf extract
Mangiferine (Mangifera indica) is a nutraceutical permitted for use in nutraceuticals and health supplements under India's FSSAI framework. Regulyze tracks its regulatory status, limits and label requirements across regulatory frameworks.
Regulatory status
| Framework | Status | Limit | Source | Last reviewed |
|---|---|---|---|---|
| India — FSSAI | Permitted | As specified / GMP | FSS (Health Supplements, Nutraceuticals…) Regulations 2022 | 2026-06-20 |
Coverage for the USA (FDA), EU (EFSA), UK, GCC and ASEAN is being added — this page updates automatically as frameworks are assessed.
About Mangiferine
Mangiferine is tracked in the Regulyze Ingredient Intelligence database as a nutraceutical (Mangifera indica). The regulatory details on this page are generated from Regulyze's structured regulatory dataset and are reviewed against the cited source.
Frequently asked questions
Is Mangiferine permitted in nutraceuticals under FSSAI (India)?
Mangiferine (Mangifera indica) (listed in the regulation as “Mangifera indica mangiferine leaf extract”) is currently permitted for use in health supplements and nutraceuticals under India's FSSAI framework, per FSS (Health Supplements, Nutraceuticals…) Regulations 2022. Always verify against the current official regulation for your product and market.
What is the permitted dosage of Mangiferine?
No single numeric limit is listed in the source for Mangiferine; permitted use is at GMP or as specified. Confirm against the current regulation.
What product category does Mangiferine belong to?
Mangiferine is classified under: Nutraceuticals, Botanicals.
What is the botanical (scientific) name of Mangiferine?
Mangiferine corresponds to Mangifera indica, with the leaf extract used in nutraceutical preparations.
Source: FSS (Health Supplements, Nutraceuticals…) Regulations 2022 · Last reviewed: 2026-06-20 · Data version: db-2026-06-20. Indicative only — verify against the current official regulation before use.